Drug
Talaporfin clinical trials
Also written LS11.
How studies write it
Studies that test it under each name
Studies by the year they started
13 studies that test it; most in 2004 (2)
| Year | Studies |
|---|---|
| 2001 | 1 |
| 2003 | 1 |
| 2004 | 2 |
| 2005 | 1 |
| 2006 | 2 |
| 2007 | 1 |
| 2008 | 2 |
| 2009 | 1 |
| 2013 | 1 |
| 2014 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 11 · Other 2
Light Sciences Oncology (7) · Light Sciences LLC (4) · University of California, Irvine (1) · Children's Hospital of Philadelphia (1)
Studies
Open first, then newest update. How each study uses Talaporfin is read from its arms, and is right about nine times in ten.
Testing it · 13
- Novel Treatment for Port Wine Stain BirthmarksCompletedPhase 1University of California, IrvineNCT01924273Written as Talaporfin sodium
- A Placebo Controlled Study of MR901 (Talaporfin Sodium Sodium + a Drug-activating Device) for the Relief of Lower Urinary Tract Symptoms Due to Benign Prostatic HyperplasiaCompletedPhase 2Light Sciences OncologyNCT02326454Written as talaporfin sodium
- Phase 3 Trial of Litx™ Plus Chemotherapy vs. Chemotherapy Only Treating Colorectal Cancer Patients With Recurrent Liver MetastasesCompletedPhase 3Light Sciences OncologyNCT00440310Written as Talaporfin sodium
- Phase I Clinical Study of the Safety of Photodynamic Therapy (PDT) Using LS11 in Children With Plexiform NeurofibromasTerminatedPhase 1Children's Hospital of PhiladelphiaNCT00716469Written as LS11
- A Phase 3 Study of Talaporfin Sodium and Interstitial Light Emitting Diodes Treating Hepatocellular Carcinoma (HCC)CompletedPhase 3Light Sciences OncologyNCT00355355Written as Talaporfin sodium
- Study of Light-Activated Talaporfin Sodium in Patients With Lower Urinary Tract Symptoms (LUTS) Due to Benign Prostatic Hyperplasia (BPH)CompletedPhase 2Light Sciences OncologyNCT00918034Written as talaporfin sodium
- Phase IIa Safety and Light Dose-escalation Study in Patients With Primary or Recurrent/High-grade Glioma Using the Litx™ System to Confirm the Zone of Tumor Destruction During the Intraoperative Treatment of GliomaCompletedPhase 2Light Sciences OncologyNCT00409214Written as LS11 (talaporfin sodium)
- Phase 1 Study of the Litx™ BPH System in Patients With Lower Urinary Tract Symptoms (LUTS) Due to Benign Prostatic Hyperplasia (BPH)CompletedPhase 1Light Sciences OncologyNCT00709488Written as Talaporfin sodium
- Study of Talaporfin Sodium Photodynamic Therapy to Treat Advanced Age Related Macular DiseaseTerminatedPhase 1Light Sciences LLCNCT00102115Written as Talaporfin Sodium (LS11) Photodynamic Therapy (PDT)
- Tumor Ablation With Talaporfin Sodium and Interstitial Light Emitting Diodes Treating Hepatocellular Carcinoma (HCC)CompletedPhase 1/2Light Sciences OncologyNCT00122876Written as Talaporfin Sodium
- Study of the Litx™ System Combined With Chemotherapy in Patients With Colorectal Liver MetastasesCompletedPhase 2Light Sciences LLCNCT00083785Written as Talaporfin sodium (LS11)
- Photodynamic Therapy With Talaporfin Sodium (LS11) in Treating Patients With Refractory Colorectal Liver MetastasesCompletedPhase 2Light Sciences LLCNCT00068068Written as Talaporfin sodium (LS11)
- Photodynamic Therapy System for Patients With Refractory/Unresponsive Solid TumorsCompletedPhase 1Light Sciences LLCNCT00028405Written as LS 11(Taporfin Sodium)
Codes
What other systems call Talaporfin · ClinicalTrials.gg INT003343
- MeSH (NLM) C053434TalaporfinConfirmed ClinicalTrials.gov, NLM, Wikidata
- UNII (FDA) P4ROX5ELT2TALAPORFINConfirmed FDA, NLM, Wikidata
- Wikidata Q7678897TalaporfinConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C90923TalaporfinOne source FDA
- DrugBank DB11812One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C053434 | Talaporfin | Confirmed ClinicalTrials.gov, NLM, Wikidata |
| UNII (FDA) | P4ROX5ELT2 | TALAPORFIN | Confirmed FDA, NLM, Wikidata |
| Wikidata | Q7678897 | Talaporfin | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C90923 | Talaporfin | One source FDA |
| DrugBank | DB11812 | — | One source Wikidata |
Also registered as talaporfin sodium (UNII L63605PZ70).
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.